Management of Multiple Sclerosis During Pregnancy and the Reproductive Years
Authors:
- Sura AlwanSASura Alwan
- Jan M. FriedmanJFJan M. Friedman
- Kerstin HellwigKHKerstin Hellwig
- Maria HoutchensMHMaria Houtchens
- Gideon KorenGKGideon Koren
- Ellen LuELEllen Lu
- Thomas F. McElrathTMThomas F. McElrath
- Penelope SmythPSPenelope Smyth
- Helen TremlettHTHelen Tremlett
- A. Dessa SadovnickASA. Dessa Sadovnick
- 1 December 2014
- journal article
- review article
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 124 (6) , 1157-1168
Abstract
To examine the evidence guiding management of multiple sclerosis (MS) in reproductive-aged women. We conducted an electronic literature search using PubMed, ClinicalTrials.gov, and other available resources. The following keywords were used: "multiple sclerosis" and "pregnancy." We manually searched the reference lists of identified studies. Two reviewers categorized all studies identified in the search by management topic, including effect of pregnancy on MS course, fetal risks associated with disease-modifying treatments during pregnancy, and management of patients off disease-modifying treatment. We categorized studies by strength of evidence and included prior meta-analyses and systematic studies. These studies were then summarized and discussed by an expert multidisciplinary team. The risk of MS relapses is decreased during pregnancy and increased postpartum. Data are lacking regarding the risks of disease-modifying treatments during pregnancy. There may be an increased risk of MS relapses after use of assisted reproductive techniques. There does not appear to be a major increase in adverse outcomes in newborns of mothers with MS. Although there are many unmet research needs, the reviewed data support the conclusion that in the majority of cases, women with MS can safely choose to become pregnant, give birth, and breastfeed children. Clinical management should be individualized to optimize both the mother's reproductive outcomes and MS course.Keywords
This publication has 148 references indexed in Scilit:
- The month of birth effect in multiple sclerosis: systematic review, meta-analysis and effect of latitudeJournal of Neurology, Neurosurgery & Psychiatry, 2012
- Vitamin D During Pregnancy and Maternal, Neonatal and Infant Health Outcomes: A Systematic Review and Meta‐analysisPaediatric and Perinatal Epidemiology, 2012
- Unintended pregnancy in the United States: incidence and disparities, 2006Contraception, 2011
- Pregnancy in multiple sclerosis: clinical and self-report scalesJournal of Neurology, 2011
- Neonatal and delivery outcomes in women with multiple sclerosisAnnals of Neurology, 2011
- Immunoregulatory factors in multiple sclerosis patients during and after pregnancy: relevance of natural killer cellsClinical and Experimental Immunology, 2007
- EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseasesAnnals of the Rheumatic Diseases, 2007
- Vitamin D DeficiencyNew England Journal of Medicine, 2007
- First trimester exposure to corticosteroids and oral cleftsBirth Defects Research Part A: Clinical and Molecular Teratology, 2003
- Prednisolone excretion in human milkThe Journal of Pediatrics, 1985